{
    "Participant": "hu085B6D", 
    "Report URL": "http://evidence.pgp-hms.org/genomes?display_genome_id=d18fa22cda64bc78b9dda13e2056c751b268ee1d&access_token=a22a34846f552419df1acd2574a7800a", 
    "Variants": [
        {
            "Allele Frequency": "0.0087", 
            "Build 37 Chromosome": "chr21", 
            "Build 37 Position": "35821680", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "High", 
            "Condition Tags": [
                "Drug response", 
                "Hearing and vision", 
                "Heart and circulatory"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "KCNE1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "14760488", 
                "16823764"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "4", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Proposed to cause drug-induced long QT syndrome by one group. Another group suggests an association with noise-induced hearing loss. Neither study found a statistical significant association for this variant after multiple hypotheses are corrected for.", 
            "URL": "http://evidence.pgp-hms.org/KCNE1-D85N", 
            "Variant Name": "KCNE1-D85N", 
            "Variant Page": "http://evidence.pgp-hms.org/KCNE1-D85N"
        }, 
        {
            "Allele Frequency": "0.023", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "FCN3", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "18261799", 
                "19535802"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": "4", 
                "Severity": "3", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Speculated to cause immunodeficiency in a patient with serious, repeated infections. A large set of patients was examined (1282) and this variant is not extremely rare (1.1% allele frequency), and so this single observation had no statistical significance. Additionally, if this phenotype is relatively rare (1% or less), then a strong disease effect in homozygotes should have resulted in many more homozygotes in the patient cohort. The lack of this observation casts significant doubt on any pathogenic hypothesis.", 
            "URL": "http://evidence.pgp-hms.org/FCN3-L117Shift", 
            "Variant Name": "FCN3-L117Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/FCN3-L117Shift", 
            "dbSNP IDs": [
                "rs28357092"
            ]
        }, 
        {
            "Allele Frequency": "0.011", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "20202930", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Muscular, skeletal, and connective tissue"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "MATN3", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "12736871"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "1", 
                "Familial": "2", 
                "Functional": null, 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "An Iceland study implicated this in causing increased osteoarthritis -- in particular, hand osteoarthritis. Because the variant is rare, the statistical significance of observations is weak. The authors estimate that individuals heterozygous for this variant have a 2.1-fold risk for hand osteoarthritis.", 
            "URL": "http://evidence.pgp-hms.org/MATN3-T303M", 
            "Variant Name": "MATN3-T303M", 
            "Variant Page": "http://evidence.pgp-hms.org/MATN3-T303M", 
            "dbSNP IDs": [
                "rs77245812"
            ]
        }, 
        {
            "Allele Frequency": "0.45", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "7870973", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Anatomical and congenital", 
                "Metabolism", 
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "MTRR", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 7, 
            "PMID List": [
                "10444342", 
                "10930360", 
                "11807890", 
                "12375236", 
                "15060097", 
                "15979034", 
                "17024475"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "3", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "2"
            }, 
            "Status": "Homozygous", 
            "Summary": "This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as \"MTRR I22M\" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.", 
            "URL": "http://evidence.pgp-hms.org/MTRR-I49M", 
            "Variant Name": "MTRR-I49M", 
            "Variant Page": "http://evidence.pgp-hms.org/MTRR-I49M", 
            "dbSNP IDs": [
                "rs1801394"
            ]
        }, 
        {
            "Allele Frequency": "0.049", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "41858876", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Anatomical and congenital", 
                "Heart and circulatory"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TGFB1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "8901839", 
                "14596813", 
                "15212689", 
                "15569360"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": null, 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "2", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant in a growth factor gene is associated with variation in TGFB1 levels; this has been associated with various pathogenic and some protective effects, including: more hepatic fibrosis progression in hep C patients, lower risk of cleft palate, anticorrelation with longevity, higher risk of myocardial infarction and lower risk of hypertension.", 
            "URL": "http://evidence.pgp-hms.org/TGFB1-R25P", 
            "Variant Name": "TGFB1-R25P", 
            "Variant Page": "http://evidence.pgp-hms.org/TGFB1-R25P", 
            "dbSNP IDs": [
                "rs1800471"
            ]
        }, 
        {
            "Allele Frequency": "0.14", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TGIF1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 1, 
            "PMID List": [
                "10556296"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Homozygous", 
            "Summary": "Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.", 
            "URL": "http://evidence.pgp-hms.org/TGIF1-P83Shift", 
            "Variant Name": "TGIF1-P83Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/TGIF1-P83Shift", 
            "dbSNP IDs": [
                "rs11571510"
            ]
        }, 
        {
            "Allele Frequency": "0.28", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "182554557", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer", 
                "Genital and urinary"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RNASEL", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "11941539", 
                "12022038", 
                "12415269", 
                "17407163"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.", 
            "URL": "http://evidence.pgp-hms.org/RNASEL-R462Q", 
            "Variant Name": "RNASEL-R462Q", 
            "Variant Page": "http://evidence.pgp-hms.org/RNASEL-R462Q", 
            "dbSNP IDs": [
                "rs486907"
            ]
        }, 
        {
            "Allele Frequency": "0.27", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "12915009", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer", 
                "Genital and urinary"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ELAC2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "12384782", 
                "15368467", 
                "18767027", 
                "20231859"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "2", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).", 
            "URL": "http://evidence.pgp-hms.org/ELAC2-S217L", 
            "Variant Name": "ELAC2-S217L", 
            "Variant Page": "http://evidence.pgp-hms.org/ELAC2-S217L", 
            "dbSNP IDs": [
                "rs4792311"
            ]
        }, 
        {
            "Allele Frequency": "0.63", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "7579472", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TP53", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "1975675", 
                "9607760", 
                "15355915", 
                "19837266", 
                "20615891", 
                "22184967"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.", 
            "URL": "http://evidence.pgp-hms.org/TP53-P72R", 
            "Variant Name": "TP53-P72R", 
            "Variant Page": "http://evidence.pgp-hms.org/TP53-P72R", 
            "dbSNP IDs": [
                "rs1042522"
            ]
        }, 
        {
            "Allele Frequency": "0.24", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "32906729", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "BRCA2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 2, 
            "PMID List": [
                "11062481", 
                "15235023"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.", 
            "URL": "http://evidence.pgp-hms.org/BRCA2-N372H", 
            "Variant Name": "BRCA2-N372H", 
            "Variant Page": "http://evidence.pgp-hms.org/BRCA2-N372H", 
            "dbSNP IDs": [
                "rs144848"
            ]
        }, 
        {
            "Allele Frequency": "0.063", 
            "Build 37 Chromosome": "chr12", 
            "Build 37 Position": "10271087", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Genital and urinary", 
                "Skin"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "CLEC7A", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "19864674"
            ], 
            "Scores": {
                "Case/Control": null, 
                "Computational": "4", 
                "Familial": "1", 
                "Functional": "2", 
                "Penetrance": "4", 
                "Severity": "1", 
                "Treatability": "5"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant has been found to impair homan mucosal antifungal defense and was implicated in vulvovaginal candidiasis and mucocutaneous infections in a Dutch family.", 
            "URL": "http://evidence.pgp-hms.org/CLEC7A-Y238X", 
            "Variant Name": "CLEC7A-Y238X", 
            "Variant Page": "http://evidence.pgp-hms.org/CLEC7A-Y238X", 
            "dbSNP IDs": [
                "rs16910526"
            ]
        }, 
        {
            "Allele Frequency": "0.86", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "231050715", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SP110", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "16803959"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.", 
            "URL": "http://evidence.pgp-hms.org/SP110-L425S", 
            "Variant Name": "SP110-L425S", 
            "Variant Page": "http://evidence.pgp-hms.org/SP110-L425S", 
            "dbSNP IDs": [
                "rs3948464"
            ]
        }, 
        {
            "Allele Frequency": "0.097", 
            "Build 37 Chromosome": "chr10", 
            "Build 37 Position": "96702047", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Drug response", 
                "Metabolism"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "CYP2C9", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 7, 
            "PMID List": [
                "8004131", 
                "15947090", 
                "17161452", 
                "17686967", 
                "19228618", 
                "19794411", 
                "19794412"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "3", 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant, also called CYP2C9*2, is a pharmacogenetic variant that modulates sensitivity for Warfarin (due to reduced metabolism). This variant is associated with Caucasians. The FDA has approved reduced recommended Warfarin dosage based on the presence of this variant.", 
            "URL": "http://evidence.pgp-hms.org/CYP2C9-R144C", 
            "Variant Name": "CYP2C9-R144C", 
            "Variant Page": "http://evidence.pgp-hms.org/CYP2C9-R144C", 
            "dbSNP IDs": [
                "rs1799853"
            ]
        }, 
        {
            "Allele Frequency": "0.22", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "16251599", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ABCC6", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "10811882", 
                "10913334", 
                "11776382", 
                "20038957"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "-1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "1", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.", 
            "URL": "http://evidence.pgp-hms.org/ABCC6-R1268Q", 
            "Variant Name": "ABCC6-R1268Q", 
            "Variant Page": "http://evidence.pgp-hms.org/ABCC6-R1268Q", 
            "dbSNP IDs": [
                "rs2238472"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": "-1", 
                "Penetrance": "0", 
                "Severity": "1", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ", 
            "URL": "http://evidence.pgp-hms.org/rs1544410", 
            "Variant Name": "rs1544410", 
            "Variant Page": "http://evidence.pgp-hms.org/rs1544410", 
            "dbSNP IDs": [
                "rs1544410"
            ]
        }, 
        {
            "Allele Frequency": "0.34", 
            "Build 37 Chromosome": "chr20", 
            "Build 37 Position": "4680251", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "PRNP", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 2, 
            "PMID List": [
                "18236005", 
                "19081515"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "0", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.\n\n", 
            "URL": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "Variant Name": "PRNP-M129V", 
            "Variant Page": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "dbSNP IDs": [
                "rs1799990"
            ]
        }, 
        {
            "Allele Frequency": "0.047", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "202074098", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "CASP10", 
            "Impact": "Protective", 
            "Inheritance": "Dominant", 
            "PMID Count": 2, 
            "PMID List": [
                "10412980", 
                "16251207"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported to have a protective effect on breast cancer. If the lifetime risk of breast cancer is 12%, women with this variant may have a lower risk of 8-9% (30% less than average).", 
            "URL": "http://evidence.pgp-hms.org/CASP10-V410I", 
            "Variant Name": "CASP10-V410I", 
            "Variant Page": "http://evidence.pgp-hms.org/CASP10-V410I", 
            "dbSNP IDs": [
                "rs13010627"
            ]
        }, 
        {
            "Allele Frequency": "0.068", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "44065090", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood", 
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "ABCG5", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19060911"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "2", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant has a mild protective effect on blood cholesterol. It is associated with slightly lower total and LDL cholesterol levels.", 
            "URL": "http://evidence.pgp-hms.org/ABCG5-R50C", 
            "Variant Name": "ABCG5-R50C", 
            "Variant Page": "http://evidence.pgp-hms.org/ABCG5-R50C", 
            "dbSNP IDs": [
                "rs6756629"
            ]
        }, 
        {
            "Allele Frequency": "0.74", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "17409572", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "KCNJ11", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "17463246", 
                "17463248", 
                "20054294"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.", 
            "URL": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "Variant Name": "KCNJ11-K23E", 
            "Variant Page": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "dbSNP IDs": [
                "rs5219"
            ]
        }, 
        {
            "Allele Frequency": "0.1", 
            "Build 37 Chromosome": "chr9", 
            "Build 37 Position": "132580901", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "TOR1A", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "18519876", 
                "19380705", 
                "20669276"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "1", 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This SNP has been shown to be benign and play a protective role against Dystonia.  ", 
            "URL": "http://evidence.pgp-hms.org/TOR1A-D216H", 
            "Variant Name": "TOR1A-D216H", 
            "Variant Page": "http://evidence.pgp-hms.org/TOR1A-D216H", 
            "dbSNP IDs": [
                "rs1801968"
            ]
        }, 
        {
            "Allele Frequency": "0.22", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "237048500", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "MTR", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "10498402", 
                "14744749", 
                "17417062", 
                "17855192"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant was weakly associated with a protective effect vs. colorectal cancer, but only in individuals with low alcohol consumption.\n\n\n", 
            "URL": "http://evidence.pgp-hms.org/MTR-D919G", 
            "Variant Name": "MTR-D919G", 
            "Variant Page": "http://evidence.pgp-hms.org/MTR-D919G", 
            "dbSNP IDs": [
                "rs1805087"
            ]
        }, 
        {
            "Allele Frequency": "0.23", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "110435231", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "IRS2", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19887537"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. \nA longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ", 
            "URL": "http://evidence.pgp-hms.org/IRS2-G1057D", 
            "Variant Name": "IRS2-G1057D", 
            "Variant Page": "http://evidence.pgp-hms.org/IRS2-G1057D", 
            "dbSNP IDs": [
                "rs1805097"
            ]
        }, 
        {
            "Allele Frequency": "0.2", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "89017961", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "TYR", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 7, 
            "PMID List": [
                "1820207", 
                "7704033", 
                "11284711", 
                "18326704", 
                "18488027", 
                "18488028", 
                "19533789"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "0", 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.", 
            "URL": "http://evidence.pgp-hms.org/TYR-R402Q", 
            "Variant Name": "TYR-R402Q", 
            "Variant Page": "http://evidence.pgp-hms.org/TYR-R402Q", 
            "dbSNP IDs": [
                "rs1126809"
            ]
        }, 
        {
            "Allele Frequency": "0.051", 
            "Build 37 Chromosome": "chr15", 
            "Build 37 Position": "89803950", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "FANCI", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "17412408"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign.", 
            "URL": "http://evidence.pgp-hms.org/FANCI-P55L", 
            "Variant Name": "FANCI-P55L", 
            "Variant Page": "http://evidence.pgp-hms.org/FANCI-P55L", 
            "dbSNP IDs": [
                "rs62020347"
            ]
        }, 
        {
            "Allele Frequency": "0.27", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "201052310", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "CACNA1S", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Common polymorphism", 
            "URL": "http://evidence.pgp-hms.org/CACNA1S-L458H", 
            "Variant Name": "CACNA1S-L458H", 
            "Variant Page": "http://evidence.pgp-hms.org/CACNA1S-L458H", 
            "dbSNP IDs": [
                "rs12742169"
            ]
        }, 
        {
            "Allele Frequency": "?", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "NEFL", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": null, 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.", 
            "URL": "http://evidence.pgp-hms.org/NEFL-S472Shift", 
            "Variant Name": "NEFL-S472Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/NEFL-S472Shift", 
            "dbSNP IDs": [
                "rs11340767"
            ]
        }, 
        {
            "Allele Frequency": "0.078", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "127609633", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Anatomical and congenital"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "FBN2", 
            "Impact": "Benign", 
            "Inheritance": "Dominant", 
            "PMID Count": 4, 
            "PMID List": [
                "9714438", 
                "10633129", 
                "16835936", 
                "17345643"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign -- initially associated with congenital contractual arachnodactyly, but later reports classify it as a nonpathogenic polymorphism.", 
            "URL": "http://evidence.pgp-hms.org/FBN2-S2580L", 
            "Variant Name": "FBN2-S2580L", 
            "Variant Page": "http://evidence.pgp-hms.org/FBN2-S2580L", 
            "dbSNP IDs": [
                "rs2291628"
            ]
        }, 
        {
            "Allele Frequency": "0.24", 
            "Build 37 Chromosome": "chr3", 
            "Build 37 Position": "37053568", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "MLH1", 
            "Impact": "Benign", 
            "Inheritance": "Dominant", 
            "PMID Count": 8, 
            "PMID List": [
                "11781295", 
                "12810663", 
                "17074586", 
                "17510385", 
                "17870204", 
                "19863800", 
                "20301390", 
                "22631669"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": "0", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.", 
            "URL": "http://evidence.pgp-hms.org/MLH1-I219V", 
            "Variant Name": "MLH1-I219V", 
            "Variant Page": "http://evidence.pgp-hms.org/MLH1-I219V", 
            "dbSNP IDs": [
                "rs1799977"
            ]
        }, 
        {
            "Allele Frequency": "0.23", 
            "Build 37 Chromosome": "chr14", 
            "Build 37 Position": "21790040", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RPGRIP1", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 2, 
            "PMID List": [
                "12920076", 
                "16272259"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "2", 
                "Familial": "-1", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.", 
            "URL": "http://evidence.pgp-hms.org/RPGRIP1-A547S", 
            "Variant Name": "RPGRIP1-A547S", 
            "Variant Page": "http://evidence.pgp-hms.org/RPGRIP1-A547S", 
            "dbSNP IDs": [
                "rs10151259"
            ]
        }, 
        {
            "Allele Frequency": "0.89", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "55529187", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PCSK9", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19351729"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is likely benign. ", 
            "URL": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "Variant Name": "PCSK9-G670E", 
            "Variant Page": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "dbSNP IDs": [
                "rs505151"
            ]
        }, 
        {
            "Allele Frequency": "1.0", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "21235475", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "APOB", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "5", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This position is almost certainly an error in the HG18 reference sequence. ", 
            "URL": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "Variant Name": "APOB-Y1422C", 
            "Variant Page": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "dbSNP IDs": [
                "rs568413"
            ]
        }, 
        {
            "Allele Frequency": "0.045", 
            "Build 37 Chromosome": "chr4", 
            "Build 37 Position": "6302889", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "WFS1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported benign in ClinVar", 
            "URL": "http://evidence.pgp-hms.org/WFS1-R456H", 
            "Variant Name": "WFS1-R456H", 
            "Variant Page": "http://evidence.pgp-hms.org/WFS1-R456H", 
            "dbSNP IDs": [
                "rs1801208"
            ]
        }, 
        {
            "Allele Frequency": "0.037", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "158624528", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SPTA1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "8844207", 
                "9067503", 
                "15384986", 
                "16150946"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant, also called alpha-IIa, has been seen frequently in individuals with recessive Hereditary spherocytosis. This appears to be the result of linkage to alpha-LEPRA (a C>T substitution at position -99 of intron 30); A970D is later reported as functionally neutral.", 
            "URL": "http://evidence.pgp-hms.org/SPTA1-A970D", 
            "Variant Name": "SPTA1-A970D", 
            "Variant Page": "http://evidence.pgp-hms.org/SPTA1-A970D", 
            "dbSNP IDs": [
                "rs35948326"
            ]
        }, 
        {
            "Allele Frequency": "0.3", 
            "Build 37 Chromosome": "chr9", 
            "Build 37 Position": "98209594", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PTCH1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "15712338"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Common polymorphism, presumed benign.", 
            "URL": "http://evidence.pgp-hms.org/PTCH1-P1315L", 
            "Variant Name": "PTCH1-P1315L", 
            "Variant Page": "http://evidence.pgp-hms.org/PTCH1-P1315L", 
            "dbSNP IDs": [
                "rs357564"
            ]
        }, 
        {
            "Allele Frequency": "0.29", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "68855363", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TPCN2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "18488028"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "Pigmentation allele.", 
            "URL": "http://evidence.pgp-hms.org/TPCN2-G734E", 
            "Variant Name": "TPCN2-G734E", 
            "Variant Page": "http://evidence.pgp-hms.org/TPCN2-G734E", 
            "dbSNP IDs": [
                "rs3829241"
            ]
        }, 
        {
            "Allele Frequency": "0.69", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "33951693", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SLC45A2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "15714523", 
                "17044855", 
                "18563784", 
                "18806926"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.", 
            "URL": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "Variant Name": "SLC45A2-L374F", 
            "Variant Page": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "dbSNP IDs": [
                "rs16891982"
            ]
        }, 
        {
            "Allele Frequency": "0.22", 
            "Build 37 Chromosome": "chr12", 
            "Build 37 Position": "33021934", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PKP2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19955750"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is a benign polymorphism.  ", 
            "URL": "http://evidence.pgp-hms.org/PKP2-L366P", 
            "Variant Name": "PKP2-L366P", 
            "Variant Page": "http://evidence.pgp-hms.org/PKP2-L366P", 
            "dbSNP IDs": [
                "rs1046116"
            ]
        }
    ]
}